Metastatic spinal cord compression: radiotherapy outcome and dose fractionation
- PMID: 12972313
- DOI: 10.1016/s0167-8140(03)00191-9
Metastatic spinal cord compression: radiotherapy outcome and dose fractionation
Abstract
Background and purpose: No standard dose fractionation has been defined for metastatic spinal cord compression. This retrospective analysis was undertaken to explore the impact of hypofractionated treatment compared to conventional multifraction treatment.
Materials and methods: One hundred and two consecutive patients referred to Mount Vernon Cancer Centre with metastatic spinal canal compression confirmed on MR scan in 95% with median age 68 years (range 32-90) and main primary tumour types breast (28%), prostate (28%) and lung (20%); 51% of patients were fully ambulant at diagnosis, 41% ambulant but with paraparesis and 9% had complete paraplegia. Spinal radiotherapy was given delivering a single dose in 32% and 20 Gy in five fractions in 64%.
Results: The median survival was 3.5 months; survival was significantly related to primary site and motor function at presentation. Normal ambulation was achieved in 58% at 2 weeks and 71% up to 2 months after treatment. No patient who presented with paraplegia regained function. At presentation 59% of patients had severe pain, which fell to 8% at 2 weeks. Comparing those patients who received one or two dose treatments with those who received protracted fractionation, the two groups were matched for age, sex, primary site and site of compression. Relatively more patients treated with one or two doses had paraplegia; 19% vs. 3%. Despite this outcome in the two groups was equivalent for motor and sphincter function and pain control.
Conclusions: Metastatic spinal canal compression carries a poor prognosis. Urgent treatment will maintain and improve motor function in patients presenting ambulant but those who have paraplegia at presentation do not improve and have a very short survival. In this series no difference in outcome was seen between patients treated with one or two radiation doses compared to multifraction treatment; a randomised trial comparing fractionation schedules would be justified.
Similar articles
-
Evaluation of five radiation schedules and prognostic factors for metastatic spinal cord compression.J Clin Oncol. 2005 May 20;23(15):3366-75. doi: 10.1200/JCO.2005.04.754. J Clin Oncol. 2005. PMID: 15908648
-
Role of radiotherapy in the treatment of motor dysfunction due to metastatic spinal cord compression: comparison of three different fractionation schedules.Int J Radiat Oncol Biol Phys. 2002 Nov 15;54(4):1160-4. doi: 10.1016/s0360-3016(02)02979-6. Int J Radiat Oncol Biol Phys. 2002. PMID: 12419444
-
Short-course versus split-course radiotherapy in metastatic spinal cord compression: results of a phase III, randomized, multicenter trial.J Clin Oncol. 2005 May 20;23(15):3358-65. doi: 10.1200/JCO.2005.08.193. Epub 2005 Feb 28. J Clin Oncol. 2005. PMID: 15738534 Clinical Trial.
-
Metastatic spinal cord compression by solid tumors.Semin Neurol. 2004 Dec;24(4):375-83. doi: 10.1055/s-2004-861532. Semin Neurol. 2004. PMID: 15637649 Review.
-
Management of metastatic spinal cord compression.Tumori. 2003 Sep-Oct;89(5):469-75. doi: 10.1177/030089160308900502. Tumori. 2003. PMID: 14870766 Review.
Cited by
-
Treatment of cervical vertebral (C1) metastasis of lung cancer with radiotherapy: A case report.Oncol Lett. 2013 Apr;5(4):1129-1132. doi: 10.3892/ol.2013.1183. Epub 2013 Feb 6. Oncol Lett. 2013. PMID: 23599751 Free PMC article.
-
Paraplegia of spinal epidural compression by metastatic breast cancer and urgent radiotherapy-timeliness for naught?J Neurooncol. 2009 Oct;95(1):101-103. doi: 10.1007/s11060-009-9902-8. Epub 2009 Apr 18. J Neurooncol. 2009. PMID: 19381438
-
Do elderly patients benefit from surgery in addition to radiotherapy for treatment of metastatic spinal cord compression?Strahlenther Onkol. 2012 May;188(5):424-30. doi: 10.1007/s00066-011-0058-z. Epub 2012 Feb 16. Strahlenther Onkol. 2012. PMID: 22349635
-
Clinical outcomes of stereotactic body radiotherapy for spinal metastases from hepatocellular carcinoma.Radiat Oncol J. 2015 Sep;33(3):217-25. doi: 10.3857/roj.2015.33.3.217. Epub 2015 Sep 30. Radiat Oncol J. 2015. PMID: 26484305 Free PMC article.
-
Prognostic factors in patients with metastatic spinal cord compression secondary to lung cancer: a systematic review of the literature.Eur Spine J. 2015 Oct;24(10):2107-13. doi: 10.1007/s00586-015-4157-x. Epub 2015 Jul 29. Eur Spine J. 2015. PMID: 26219914
MeSH terms
LinkOut - more resources
Full Text Sources